packageTelavancin

telavancin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Telavancin is a lipoglycopeptide antibiotic used to treat bacterial pneumonia and other serious infections such as staphylococcal, skin, and soft tissue infections. It remains an approved medicine, but its marketing authorisation in the European Union was withdrawn, so it is no longer available there.

Summary written by glm-5.3-flash from Wikidata Q7695658 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:telavancin
ATC codes:J01XA03
DrugBank:DB06402
PubChem CID:3081362
ChEBI:71229
Wikidata:Q7695658
formula:C80H106Cl2N11O27P
molar mass:1755.65 g/mol (PubChem CID 3081362)
logP:-2.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown